MikroScore
Evidence-Based Ingredient Research

Ingredient Dossiers

119 ingredients

What do the studies really say? Each dossier with evidence level, safety rating, and EU regulatory status.

Editorial note: The summaries on this overview page condense study evidence and regulatory context. They are not health claims under EU Regulation No 1924/2006 and not recommendations for the treatment, alleviation, or prevention of disease.

119 entries

5-HTP (5-Hydroxytryptophan)

Moderate Evidence

5-HTP is a serotonin precursor crossing the blood-brain barrier. Used for sleep and mood. Critical: avoid with SSRIs or MAO inhibitors due to serotonin syndrome risk.

Other EFSA: no claims Use with caution

Acetyl-L-Carnitin

Weak Evidence

ALCAR is the brain-accessible form of carnitine popular in cognitive and healthy aging stacks, but evidence is solid rather than remarkable.

Metabolic EFSA: no claims Likely safe

Alpha-Ketoglutarat (AKG)

Animal Studies Only

AKG is popular in healthy aging circles, especially as Ca-AKG, but human evidence for anti-aging effects remains extremely limited.

Metabolic EFSA: no claims Likely safe

Akkermansia muciniphila

Moderate Evidence

Akkermansia muciniphila is a gut bacterium linked to better metabolism, intestinal barrier function, and healthy aging in observational studies.

Other EFSA: no claims Likely safe

Alpha-GPC

Weak Evidence

Alpha-GPC is a bioavailable choline form with solid brain plausibility. Data for focus and cognition are interesting but not robustly compelling.

Other EFSA: no claims Likely safe

Alpha-Liponsäure (R-ALA)

Moderate Evidence

Mitochondrial antioxidant with dual water/fat solubility. R-form significantly more bioavailable than racemic mixture. Evidence strongest for diabetic neuropathy.

Antioxidants EFSA: no claims Likely safe

Apigenin

Weak Evidence

Apigenin is a flavonoid from chamomile and parsley that inhibits CD38, an enzyme that degrades NAD+. Complements NMN/NR approaches. Early human evidence.

Antioxidants EFSA: no claims Likely safe

Ashwagandha (Withania somnifera)

Moderate Evidence

Ashwagandha is an Ayurvedic adaptogen backed by multiple RCTs for stress and cortisol reduction. Sleep and testosterone effects are promising but come from small studies.

Adaptogens EFSA: no claims Likely safe

Astaxanthin

Weak Evidence

Astaxanthin is a membrane-spanning carotenoid antioxidant. Small RCTs show consistent benefits for skin protection and visual fatigue; cardiovascular and longevity data remain limited.

Antioxidants EFSA: no claims Likely safe

Astragalus

Animal Studies Only

Astragalus is traditionally positioned for immunity and longevity, but modern human evidence for these claims is quite thin.

Adaptogens EFSA: no claims Likely safe

Bacopa monnieri

Moderate Evidence

Bacopa is among the more credible herbal nootropics with decent data for memory, though effects remain moderate rather than dramatic.

Adaptogens EFSA: no claims Likely safe

Baicalin

Animal Studies Only

Baicalin is a TCM flavonoid with an interesting anti-inflammatory and neuroprotective story, but clinical evidence remains early-stage.

Antioxidants EFSA: no claims Likely safe

Berberine

Moderate Evidence

Berberine shows clinically relevant blood glucose and LDL effects in RCTs for type 2 diabetes. Significant drug interactions and unclear EU regulatory status require caution.

Metabolic EFSA: no claims Use with caution

Beta-Alanin

Strong Evidence

Beta-alanine elevates muscle carnosine and improves high-intensity exercise performance in 60–240-second efforts; it's a sports tool, not a longevity supplement.

Metabolic EFSA: no claims Likely safe

Beta-Glucan

Moderate Evidence

Beta-glucans vary by source: oat forms are solid for cholesterol; fungal forms for immunity have weaker human evidence.

Other EFSA: approved Well studied

Betain (Trimethylglycin)

Moderate Evidence

Betaine is a natural methyl donor that lowers homocysteine and shows modest strength gains in some studies, but evidence is inconsistent and limited.

Metabolic EFSA: no claims Likely safe

Bor

Weak Evidence

Boron is discussed for bone, hormone, and inflammation support. Mechanistically interesting, but human evidence remains sparse.

Other EFSA: no claims Use with caution

Calcium

Strong Evidence

Essential mineral for bones, muscles, and nerves. Meta-analyses show moderate bone effects in deficiency; high-dose supplements carry cardiovascular risks.

Other EFSA: approved Likely safe

CDP-Cholin

Weak Evidence

CDP-choline is an interesting choline form for brain and membrane metabolism. Evidence is solid but not strong enough for major claims.

Other EFSA: no claims Likely safe

Cholin

Strong Evidence

Choline is essential for cell membranes, liver, and acetylcholine production. Important if underprovisioned—but not all choline forms deliver the same brain benefits.

Other EFSA: approved Likely safe

Chrom

Weak Evidence

Chromium is often marketed for blood glucose and appetite control. The evidence is mixed, and in healthy individuals, the added benefit is usually small.

Metabolic EFSA: approved Likely safe

Cistanche

Animal Studies Only

Cistanche is a TCM botanical gaining longevity popularity, but human evidence remains limited and mainly rests on preclinical data.

Adaptogens EFSA: no claims Likely safe

CoQ10 (Ubiquinol / Ubiquinone)

Moderate Evidence

CoQ10 reduces mortality in heart failure (Q-SYMBIO); relieves statin-induced muscle pain. In healthy individuals without heart disease, benefits are unproven.

Antioxidants EFSA: no claims Well studied

Cordyceps

Weak Evidence

Cordyceps is marketed for energy and endurance. The evidence is intriguing but mixed—no strong support for major performance claims.

Adaptogens EFSA: no claims Likely safe

Curcumin (Turmeric Extract)

Moderate Evidence

Curcumin modulates inflammatory and oxidative pathways; moderate effects on CRP, IL-6, and joint pain—but only with enhanced formulations. Bioavailability is the limiting factor.

Antioxidants EFSA: no claims Likely safe

D,L-Phenylalanine

Weak Evidence

DLPA combines the neurotransmitter precursor L-phenylalanine with the D-form, which may prolong endogenous endorphins. Moderate evidence, older study base.

cognitive EFSA: no claims Likely safe

EGCG (Grüntee-Extrakt)

Moderate Evidence

EGCG is green tea's most abundant catechin, studied for metabolism and cellular protection. High-dose supplements carry documented liver toxicity risks.

Antioxidants EFSA: no claims Use with caution

Iron

Strong Evidence

Essential for oxygen transport, energy metabolism, and immune function. Clearly effective when deficiency is confirmed — do not supplement without a lab diagnosis.

Other EFSA: approved Use with caution

Ergothionein

Weak Evidence

Ergothioneine is a sulfur-containing amino acid found primarily in mushrooms, studied for potential antioxidant and age-related benefits despite limited human evidence.

Antioxidants EFSA: no claims Likely safe

Fisetin

Weak Evidence

Fisetin is a flavonoid senolytic that clears senescent ('zombie') cells in animal studies. Human trials are ongoing; robust clinical evidence is still lacking.

Senolytics EFSA: no claims Insufficient data

Flohsamenschalen (Psyllium)

Strong Evidence

Well-studied soluble fiber for digestive health; also shown to benefit cholesterol and glucose markers. Low hype, high utility.

Other EFSA: approved Well studied

Folsäure (Vitamin B9)

Strong Evidence

Essential B-vitamin for DNA synthesis, cell division, and homocysteine metabolism. Strong evidence for neural tube defect prevention in pregnancy. L-methylfolate benefits MTHFR carriers.

Metabolic EFSA: approved Likely safe

Fucoidan

Weak Evidence

Fucoidan is a sulfated polysaccharide from brown seaweed with growing evidence for prebiotic gut effects, muscle health, and cardiovascular markers.

general-health EFSA: no claims Likely safe

GABA

Animal Studies Only

GABA seems logical for relaxation and sleep, but faces a major bioavailability problem: oral doses likely reach the brain only partially, limiting measurable effects.

Other EFSA: no claims Likely safe

Ginkgo biloba

Weak Evidence

Popular nootropic extract with mixed evidence for memory and circulation. Heterogeneous study results and significant interaction risk with anticoagulants require careful consideration.

Adaptogens EFSA: no claims Use with caution

Ginseng (Panax)

Weak Evidence

Ginseng is a classical adaptogen for energy and stress, but evidence is mixed and highly extract-dependent. More serious than trend ingredients, yet less effective than marketing suggests.

Adaptogens EFSA: no claims Use with caution

Glucosamin

Weak Evidence

Glucosamine is a classic joint supplement with mixed evidence. Some data supports potential benefits, but not enough to warrant broad therapeutic claims.

Other EFSA: no claims Likely safe

Glutathion

Weak Evidence

Glutathione is the body's most celebrated antioxidant. As a supplement, the evidence is far less impressive than its reputation.

Antioxidants EFSA: no claims Likely safe

Glycin

Moderate Evidence

Glycine is the smallest amino acid, required for glutathione, collagen, and creatine. In GlyNAC form, it shows promise for aging markers in older adults.

Metabolic EFSA: no claims Well studied

GlyNAC (Glycin + NAC)

Moderate Evidence

GlyNAC combines glycine and N-acetylcysteine (NAC) to support glutathione synthesis. Early clinical data in healthy aging contexts are promising but still limited.

Antioxidants EFSA: no claims Likely safe

Gotu Kola

Weak Evidence

Gotu Kola is discussed for vascular, skin, and cognitive support. Evidence is interesting but inconsistent rather than robust.

Adaptogens EFSA: no claims Likely safe

Gynostemma (Jiaogulan)

Weak Evidence

Gynostemma (Jiaogulan) is an adaptogenic herb from Southeast Asia that activates AMPK like metformin, and is associated with longevity in Chinese populations.

Adaptogens EFSA: no claims Likely safe

Hesperidin

Weak Evidence

Citrus flavonoid with promising vascular and anti-inflammatory evidence in preclinical and small human studies, but overall support remains moderate.

Antioxidants EFSA: no claims Likely safe

Hyaluronsäure

Moderate Evidence

Endogenous glycosaminoglycan with high water-binding capacity. Multiple RCTs demonstrate moderate effects on skin hydration and wrinkle reduction; oral joint data weaker.

Other EFSA: no claims Likely safe

Hydroxytyrosol

Moderate Evidence

Hydroxytyrosol is an olive polyphenol studied for oxidative stress and vascular markers. One of the few EFSA-approved polyphenol claims.

Antioxidants EFSA: approved Well studied

Inulin (Prebiotikum)

Moderate Evidence

Inulin is a prebiotic fiber with solid biological plausibility for gut health. Practically beneficial, but not an aging shortcut.

Other EFSA: no claims Likely safe

Jod

Strong Evidence

Iodine is essential for thyroid hormones and cognitive development. Germany faces structural deficiency despite salt iodization. EFSA-approved claims.

Metabolic EFSA: approved Use with caution

Kaempferol

Animal Studies Only

Kaempferol is another flavonoid perpetual: mechanistically intriguing, clinically thin. Interesting for research, not for health claims.

Antioxidants EFSA: no claims Likely safe

Kalium

Strong Evidence

Potassium is essential for blood pressure, nerves and muscles. Often more important via diet than supplementation—and potentially risky when overdosed.

Other EFSA: approved Use with caution

Caffeine

Strong Evidence

The world's most widely consumed psychoactive substance. Hundreds of RCTs confirm effects on alertness, reaction time, endurance, and short-term cognition.

Metabolic EFSA: no claims Likely safe

Kollagen

Moderate Evidence

Collagen is one of the most popular supplements. Human trials support benefits for skin elasticity and joint markers; broader anti-aging claims remain unproven.

Other EFSA: no claims Well studied

Creatine (Creatine Monohydrate)

Strong Evidence

Creatine is one of the most thoroughly studied supplements for high-intensity muscular work. The strongest evidence is from strength and power sports; further applications are still being explored.

Metabolic EFSA: approved Likely safe

Pumpkin Seed Oil

Weak Evidence

Pumpkin seed oil contains phytosterols and delta-7 sterols linked to prostate and bladder health. Moderate evidence from small RCTs.

hormonal EFSA: no claims Likely safe

Kupfer

Strong Evidence

Copper is essential for enzymes, iron metabolism, and connective tissue. Justified for deficiency—but high-dose supplementation isn't advisable for otherwise healthy individuals.

Other EFSA: approved Use with caution

L-Carnitin

Weak Evidence

L-Carnitine shuttles fatty acids into mitochondria. Sounds like a fat burner, but typically delivers less than marketing promises for healthy people.

Metabolic EFSA: no claims Likely safe

L-Citrullin

Moderate Evidence

L-citrulline may boost nitric oxide production and is linked in studies to improved blood flow and endurance performance during physical exertion.

Metabolic EFSA: no claims Likely safe

L-Glutamine

Moderate Evidence

L-glutamine is the most abundant free amino acid in the body. Clinically well-supported in critical care; evidence for oral supplementation in healthy individuals is more limited.

Metabolic EFSA: no claims Well studied

Lactobacillus reuteri

Weak Evidence

Strain-specific probiotic with RCT evidence for bone health in older women. Reduced bone loss by ~50% over 12 months.

general-health EFSA: no claims Likely safe

L-Theanine

Moderate Evidence

L-theanine promotes relaxed alertness via alpha-wave activation. Best evidence for caffeine synergy; moderate effects on stress markers. Alone, cognitive benefits are limited.

Other EFSA: no claims Likely safe

L-Tryptophan

Weak Evidence

L-tryptophan is the precursor to serotonin and melatonin. Biologically plausible for sleep and mood, but direct supplementation effects remain limited and variable.

Other EFSA: no claims Use with caution

L-Tyrosin

Moderate Evidence

L-Tyrosin is an amino acid precursor of dopamine, noradrenaline, and adrenaline. Studies show cognitive benefits under acute stress and sleep deprivation.

Other EFSA: no claims Likely safe

Lion's Mane (Hericium erinaceus)

Weak Evidence

Edible mushroom with active compounds (hericenones, erinacines) that stimulate NGF and BDNF synthesis. Early RCTs in MCI and anxiety show positive signals — evidence remains preliminary.

Other EFSA: no claims Likely safe

Lithium (Orotat)

Animal Studies Only

Lithium oroate is hyped for mood and neurobiological research. Evidence is sparse while safety and regulatory concerns remain uncertain.

Other EFSA: no claims Use with caution

Lutein & Zeaxanthin

Moderate Evidence

Xanthophyll carotenoids that concentrate in the macula. Strong evidence for slowing AMD progression (25% reduction in AREDS2). Also studied for contrast sensitivity, glare, and cognitive function.

Antioxidants EFSA: approved Well studied

Luteolin

Animal Studies Only

Luteolin is an intriguing flavonoid with neuroprotective and anti-inflammatory potential. The catch: human evidence lags significantly behind the mechanistic story.

Antioxidants EFSA: no claims Likely safe

Maca

Weak Evidence

Marketed for libido, energy, and hormonal balance. Human data exist but are modest in size and strength—weaker evidence than typical promotion suggests.

Adaptogens EFSA: no claims Likely safe

Magnesium

Strong Evidence

Magnesium is involved in over 300 enzymatic reactions. Low intake is common. The form significantly affects bioavailability and tolerability.

Metabolic EFSA: approved Well studied

Mangan

Strong Evidence

Manganese is an essential trace element for enzyme function, bone metabolism and antioxidant systems. Deficiency is rare; supplementation in healthy adults lacks clear evidence of benefit.

Other EFSA: approved Use with caution

Melatonin

Strong Evidence

Melatonin regulates the sleep–wake cycle and has antioxidant properties. Evidence is strongest for jet lag and sleep onset; prescription-only above 0.5 mg/day in Germany.

Other EFSA: approved Likely safe

Molybdän

Strong Evidence

Molybdenum is an essential trace element for certain enzymes. Deficiency is rare, and there is usually little reason for supplementation.

Other EFSA: approved Well studied

MSM

Weak Evidence

MSM is marketed mainly for joint health and inflammation. The data aren't empty, but significantly smaller than most claims suggest.

Other EFSA: no claims Likely safe

Multivitamin

Moderate Evidence

Multivitamins are the world's best-selling supplements. Evidence for health benefits in well-nourished individuals is surprisingly weak.

general-health EFSA: approved Likely safe

Myo-Inositol

Moderate Evidence

Myo-inositol has solid RCT evidence for PCOS and insulin resistance. Promising but limited data for anxiety and panic disorder.

Metabolic EFSA: no claims Likely safe

NAC (N-Acetylcysteine)

Moderate Evidence

NAC is a glutathione precursor with established medical use. As a longevity supplement (especially as GlyNAC), early human data is promising but limited.

Antioxidants EFSA: no claims Likely safe

NMN (Nicotinamide Mononucleotide)

Moderate Evidence

NMN is a direct precursor to NAD+. Animal studies are promising — robust human trials are still lacking, and the EU regulatory status is unclear.

NAD Precursors EFSA: no claims Likely safe

NR (Nicotinamide Riboside)

Moderate Evidence

Like NMN, NR is a NAD+ precursor — but unlike NMN, it is approved as a Novel Food in the EU. Human studies confirm NAD+ elevation; clinical benefits remain unclear.

NAD Precursors EFSA: no claims Likely safe

Omega-3 (EPA + DHA)

Strong Evidence

Omega-3 fatty acids (EPA + DHA) are among the most thoroughly studied supplements. Evidence is strong for triglycerides and high-risk cardiovascular patients; smaller for healthy individuals.

Other EFSA: approved Well studied

Phosphatidylserin

Moderate Evidence

Phosphatidylserine is a membrane phospholipid with an EFSA-approved health claim for maintaining normal cognitive function at 100 mg/day.

Other EFSA: approved Likely safe

Phosphor

Strong Evidence

Phosphorus is essential for bones, ATP and cell membranes. Deficiency is rare, and supplements are unnecessary for most people.

Other EFSA: approved Likely safe

Piperin

Moderate Evidence

Piperine boosts bioavailability of nutrients like curcumin, but its effects on absorption and drug metabolism create potential for supplement and drug interactions.

Other EFSA: no claims Use with caution

PQQ

Animal Studies Only

PQQ is often linked to mitochondria and cellular energy. It sounds elegant, but human evidence remains limited.

Antioxidants EFSA: no claims Likely safe

Probiotics

Moderate Evidence

Probiotics are live microorganisms with strain-specific effects. Strong evidence for antibiotic diarrhea and IBS; product quality varies dramatically.

Other EFSA: no claims Likely safe

Pterostilben

Weak Evidence

Pterostilbene is a resveratrol analogue from blueberries with superior bioavailability (~80% vs 20%). Similar mechanisms (SIRT1, AMPK) but fewer human studies to date.

Antioxidants EFSA: no claims Likely safe

Quercetin

Weak Evidence

Quercetin is a plant flavonoid with antioxidant and senolytic potential. Human senolytic evidence is limited to tiny pilot studies using Dasatinib+Quercetin combined — not quercetin alone.

Senolytics EFSA: no claims Likely safe

Rapamycin (Sirolimus)

Weak Evidence

Rapamycin is the best-supported longevity drug in animal studies, but it is prescription-only and not approved for anti-aging use in humans.

Other EFSA: no claims Use with caution

Reishi

Animal Studies Only

Reishi is among the most famous medicinal mushrooms. The immune support and longevity narrative is compelling, but human evidence remains limited.

Adaptogens EFSA: no claims Use with caution

Resveratrol

Weak Evidence

Known for sirtuin activation in animal models. Poor oral bioavailability (<1% free form) translates poorly to humans; a 2026 umbrella review found no convincing metabolic effects even in diabetics.

Antioxidants EFSA: no claims Likely safe

Rhodiola Rosea (Rosenwurz)

Moderate Evidence

Rhodiola rosea is an adaptogen with RCT evidence for mental fatigue and stress relief. Data are promising but show some heterogeneity across studies.

Adaptogens EFSA: no claims Likely safe

Rutin

Weak Evidence

Rutin is a flavonoid with vascular and antioxidant properties. Biologically plausible but clinically a niche topic with limited human evidence.

Antioxidants EFSA: no claims Likely safe

Saffron (Crocus sativus)

Moderate Evidence

Saffron is mainly studied for mood, stress, and PMS. Human trials are interesting, but still too small and narrow to justify broad health claims or premium pricing narratives.

Other EFSA: no claims Likely safe

SAMe

Moderate Evidence

SAMe supports mood, liver function, and methylation as a central methyl donor. It has clinical evidence but is regarded as more therapeutic than typical supplements.

Metabolic EFSA: no claims Use with caution

Schisandra

Weak Evidence

Classic adaptogenic berry used for stress resilience and liver support. Traditional use is extensive, but human clinical evidence remains modest and inconsistent.

Adaptogens EFSA: no claims Likely safe

Irish Sea Moss

No Studies

Irish Sea Moss is a red algae marketed as a natural mineral source. Viral on social media but virtually no clinical evidence for health benefits.

general-health EFSA: no claims Use with caution

Selen

Strong Evidence

Selenium is essential for glutathione peroxidases and thyroid hormones. In Germany and Austria, selenium supply is structurally low due to selenium-depleted soils.

Antioxidants EFSA: approved Use with caution

Shilajit

Animal Studies Only

Shilajit is marketed for energy, testosterone, and mitochondrial health, but human data is limited and product quality issues are a genuine concern.

Other EFSA: no claims Use with caution

Silicium

Weak Evidence

Silicon is marketed for skin, hair, nails and connective tissue. Biologically plausible but clinical evidence is limited.

Other EFSA: no claims Likely safe

Silymarin (Mariendistel)

Weak Evidence

Silymarin is the classic liver compound. Evidence exists but is considerably mixed compared to its reputation in detox and liver support products.

Other EFSA: no claims Likely safe

Spermidine

Weak Evidence

Natural polyamine from wheat germ and legumes. Robustly induces autophagy in cell and animal models; early human trials show positive signals for cognition and heart function.

Other EFSA: no claims Likely safe

Sulforaphan

Moderate Evidence

Sulforaphan activates Nrf2-dependent defence mechanisms and is typically sourced from broccoli sprouts. Strong preclinical evidence; clinical data still building.

Antioxidants EFSA: no claims Likely safe

Taurin

Moderate Evidence

Taurine is an amino acid with a central role in energy metabolism. Animal and observational data have sparked aging research interest; robust human evidence is far more limited.

Metabolic EFSA: no claims Likely safe

TMG (Trimethylglycin)

Weak Evidence

TMG provides methyl groups and correlates with lower homocysteine. Biochemically plausible but as a healthy aging supplement, it's more niche than essential.

Metabolic EFSA: no claims Likely safe

Tongkat Ali

Weak Evidence

Popular in male health stacks, but evidence is small, extract-dependent, and not hype-free. Interesting signals but modest robustness.

Adaptogens EFSA: no claims Use with caution

Trehalose

Weak Evidence

Trehalose is a natural disaccharide investigated for autophagy activation in animal models. Human evidence is limited, but early data suggest metabolic benefits.

Metabolic EFSA: no claims Likely safe

Urolithin A

Moderate Evidence

Urolithin A is a gut microbiome metabolite from pomegranate polyphenols, emerging in aging research as a mitophagy inducer.

Metabolic EFSA: no claims Likely safe

Vitamin A

Strong Evidence

Essential for vision, skin, and immune function. Clearly useful for deficiency, but high doses are toxic—especially in pregnancy.

Other EFSA: approved Use with caution

Vitamin B1 (Thiamin)

Strong Evidence

Vitamin B1 (thiamine) is essential for energy metabolism and nerve function. Supplements address deficiency and help high-risk groups—not a general anti-aging compound.

Other EFSA: approved Well studied

Vitamin B12 (Cobalamin)

Strong Evidence

Vitamin B12 is essential for nerve function, DNA synthesis, and homocysteine metabolism. Deficiency is common in vegans, older adults, and metformin users and causes irreversible nerve damage.

Metabolic EFSA: approved Well studied

Vitamin B2 (Riboflavin)

Moderate Evidence

Vitamin B2 is essential for energy metabolism and antioxidant defence. Most relevant for deficiency correction and potentially for migraine prevention in susceptible individuals.

Other EFSA: approved Well studied

Vitamin B3 (Niacin)

Moderate Evidence

Vitamin B3 is essential and a NAD+ precursor. While deficiency correction matters, high-dose niacin causes side effects—benefits for aging in healthy adults remain unclear.

NAD Precursors EFSA: approved Use with caution

Vitamin B5 (Pantothensäure)

Strong Evidence

Vitamin B5 is essential for CoA and energy metabolism. Deficiency is rare—extra supplements bring little with adequate intake.

Other EFSA: approved Well studied

Vitamin B6

Strong Evidence

Vitamin B6 is essential for amino acid metabolism, nerve function, and blood cell formation. Useful for deficiency—chronic high doses can cause nerve damage.

Other EFSA: approved Use with caution

Vitamin B7 (Biotin)

Weak Evidence

Biotin is essential but deficiency is rare. For hair and nails only truly beneficial if a deficiency exists – plus lab values can be distorted.

Other EFSA: approved Use with caution

Vitamin C (Ascorbic Acid)

Strong Evidence

Vitamin C is essential for collagen synthesis and other normal body functions, with approved EFSA claims. Megadoses show no clear benefit beyond adequate intake.

Antioxidants EFSA: approved Likely safe

Vitamin D3

Strong Evidence

Vitamin D3 is well supported for bone, muscle, and immune function when deficiency is confirmed. Without deficiency, additional benefit is significantly weaker — not a universal upgrade.

Other EFSA: approved Likely safe

Vitamin D3 + K2

Strong Evidence

Low vitamin D levels are common in northern climates. Supplementation is comparatively well studied in deficiency; K2 is often combined but has weaker standalone evidence.

Other EFSA: approved Well studied

Vitamin E (Tocopherole)

Moderate Evidence

Vitamin E: 8 lipid-soluble antioxidants protecting cell membranes. Natural mixed tocopherols are generally safe; high-dose synthetic forms carry risks documented in the SELECT trial.

Antioxidants EFSA: approved Use with caution

Vitamin K1

Moderate Evidence

Vitamin K1 is essential for blood clotting and likely important for bone metabolism. Supplementation makes sense with low intake but is medically relevant for anticoagulant users.

Other EFSA: approved Use with caution

Vitamin K2 (MK-7)

Moderate Evidence

Vitamin K2 activates calcium-regulating proteins and is studied primarily for bone and vascular health. MK-7 from natto demonstrates good bioavailability.

Metabolic EFSA: approved Likely safe

Zinc

Strong Evidence

Zinc is involved in hundreds of enzymes and is essential for immune function, DNA repair, and hormone synthesis. Low intake is not uncommon in older adults and vegans.

Metabolic EFSA: approved Likely safe